YG
Yash Garg
About Yash Garg
Yash Garg has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Trignite Tech Private Limited and Simran Analytics Private Limited. Formerly with 2 companies, such as Supernova Bioscience & Formulations Private Limited and Kahan Transformer Private Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Trignite Tech Private Limited
U85223UP2025PTC237368
|
Director | 02 Dec 2025 | 2025 | Active |
Simran Analytics Private Limited
U74999UP2022PTC160896
|
Director | 20 Nov 2024 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Supernova Bioscience & Formulations Private Limited
U24239UP2022PTC159832
|
Director | 21 Feb 2022 | 2022 | Active |
Kahan Transformer Private Limited
U31102UP1989PTC010782
|
Additional Director | 15 Feb 2021 | 1989 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yash Garg
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yash Garg
Yash Garg has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Trignite Tech Private Limited and Simran Analytics Private Limited. Formerly with 2 companies, such as Supernova Bioscience & Formulations Private Limited and Kahan Transformer Private Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Yash Garg is associated with 2 companies as Director.
Yash Garg has expertise in Technology, General Business.
Yash Garg has 5 years in corporate governance.